0001415889-21-000970.txt : 20210225 0001415889-21-000970.hdr.sgml : 20210225 20210225200208 ACCESSION NUMBER: 0001415889-21-000970 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210223 FILED AS OF DATE: 20210225 DATE AS OF CHANGE: 20210225 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sheena Jonathan CENTRAL INDEX KEY: 0001646649 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37478 FILM NUMBER: 21682894 MAIL ADDRESS: STREET 1: C/O NATERA, INC. STREET 2: 201 INDUSTRIAL ROAD, SUITE 410 CITY: SAN CARLOS STATE: CA ZIP: 94070 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Natera, Inc. CENTRAL INDEX KEY: 0001604821 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 010894487 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 201 INDUSTRIAL ROAD STREET 2: SUITE 410 CITY: SAN CARLOS STATE: CA ZIP: 94070 BUSINESS PHONE: 650-249-9090 MAIL ADDRESS: STREET 1: 201 INDUSTRIAL ROAD STREET 2: SUITE 410 CITY: SAN CARLOS STATE: CA ZIP: 94070 4 1 form4-02252021_050256.xml X0306 4 2021-02-23 0001604821 Natera, Inc. NTRA 0001646649 Sheena Jonathan C/O NATERA, INC. 13011 MCCALLEN PASS BUILDING A SUITE 100 AUSTIN TX 78753 true true false false CO-FOUNDER Common Stock 2021-02-23 4 A 0 3225 0 A 436085 D Common Stock 2021-02-24 4 M 0 10000 1.141 A 446085 D Common Stock 2021-02-25 4 S 0 1038 106.6918 D 445047 D Stock Option (right to buy) 1.141 2021-02-24 4 M 0 10000 0 D 2022-09-20 Common Stock 10000 126950 D On April 12, 2019, the Reporting Person was granted a performance-based Restricted Stock Units (the "RSUs") covering 6,450 shares of common stock, which vests in tranches upon the Issuer achieving certain specified financial and operating metrics. On February 23, 2021, the milestones were satisfied for the vesting of RSUs covering 3,225 shares of common stock. The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs pursuant to Rule 10b5-1. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.68 o $106.9112 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The option shares are fully vested and may be exercised at any time. /s/ Tami Chen, Attorney-in-Fact 2021-02-25